Northern Trust’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-24,080
| Closed | -$274K | – | 4559 |
|
|
2023
Q4 | $274K | Buy |
+24,080
| New | +$274K | ﹤0.01% | 3764 |
|
|
2023
Q3 | – | Sell |
-3,766
| Closed | -$26.7K | – | 4563 |
|
|
2023
Q2 | $26.7K | Sell |
3,766
-1,529
| -29% | -$10.9K | ﹤0.01% | 4347 |
|
|
2023
Q1 | $39.4K | Sell |
5,295
-4
| -0.1% | -$30 | ﹤0.01% | 4315 |
|
|
2022
Q4 | $38.5K | Hold |
5,299
| – | – | ﹤0.01% | 4346 |
|
|
2022
Q3 | $52K | Hold |
5,299
| – | – | ﹤0.01% | 4316 |
|
|
2022
Q2 | $101K | Sell |
5,299
-13,137
| -71% | -$250K | ﹤0.01% | 4165 |
|
|
2022
Q1 | $916K | Sell |
18,436
-689
| -4% | -$34.2K | ﹤0.01% | 3459 |
|
|
2021
Q4 | $1.44M | Sell |
19,125
-681
| -3% | -$51.4K | ﹤0.01% | 3393 |
|
|
2021
Q3 | $1.57M | Sell |
19,806
-1,131
| -5% | -$89.4K | ﹤0.01% | 3392 |
|
|
2021
Q2 | $2.9M | Buy |
20,937
+3,066
| +17% | +$425K | ﹤0.01% | 3175 |
|
|
2021
Q1 | $3.74M | Buy |
17,871
+2,113
| +13% | +$442K | ﹤0.01% | 2920 |
|
|
2020
Q4 | $2.62M | Sell |
15,758
-587
| -4% | -$97.5K | ﹤0.01% | 3060 |
|
|
2020
Q3 | $2.78M | Buy |
16,345
+1,139
| +7% | +$194K | ﹤0.01% | 2886 |
|
|
2020
Q2 | $2.53M | Buy |
15,206
+6,178
| +68% | +$1.03M | ﹤0.01% | 2911 |
|
|
2020
Q1 | $1.04M | Buy |
9,028
+969
| +12% | +$112K | ﹤0.01% | 3200 |
|
|
2019
Q4 | $1.19M | Sell |
8,059
-525
| -6% | -$77.7K | ﹤0.01% | 3336 |
|
|
2019
Q3 | $1.17M | Buy |
8,584
+5,009
| +140% | +$684K | ﹤0.01% | 3339 |
|
|
2019
Q2 | $465K | Buy |
3,575
+308
| +9% | +$40.1K | ﹤0.01% | 3572 |
|
|
2019
Q1 | $309K | Buy |
+3,267
| New | +$309K | ﹤0.01% | 3668 |
|